Remission outcomes in severe eosinophilic asthma with mepolizumab therapy : Analysis of the REDES study
-
Pavord, Ian (University of Oxford)
;
Gardiner, Frances (GSK House) ;
Heaney, Liam G. (Queen's University Belfast) ;
Domingo, Christian (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Price, Robert G. (Biostatistics, GSK) ;
Pullan, Alison (Plus-Project Partnership Ltd) ;
Oppenheimer, John (UMDNJ-Rutgers New Jersey Medical School) ;
Brusselle, Guy (Universitair Ziekenhuis Gent) ;
Nagase, Hiroyuki (Teikyo University School of Medicine) ;
Chupp, Geoffrey (Yale Center for Asthma and Airways Disease (YCAAD)) ;
Pizzichini, Emilio (Federal University of Santa Catarina) ;
Bañas-Conejero, David (GSK) ;
Howarth, Peter (GSK House) ;
Universitat Autònoma de Barcelona
visitante ::
identificación
Subscribirse to this discussion. You will then receive all new comments by email.
